Federal contractor · ATHENS, GA

NYTRICX, INC.

No contract obligations recorded for NYTRICX, INC. in FY2026. Since FY2024: $746K. It also received $314.3K in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
GF9DV4ACBHH8
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 746KFY2024
  2. 0FY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for NYTRICX, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

NYTRICX, INC. received $314.3K in federal assistance in FY2026, on 2 actions (1 new awards). Its largest program was 93.837 · Cardiovascular Diseases Research ($314.3K).

Assistance · FY2026
$314.3K
New awards
1
Actions
2
Since FY2023
$4.4M

Assistance by fiscal year

  1. 2.6MFY2023
  2. 1.5MFY2024
  3. 0FY2025
  4. 314.3KFY2026

By type

  1. Grants$314.3K100%

Top programs

  1. 93.837 · Cardiovascular Diseases Research$314.3K100%

Awarding agencies

  1. National Institutes of Health$314.3K100%
    Department of Health and Human Services

Largest awards

  1. ENGINEERING NITRIC OXIDE RELEASING INTRAVASCULAR CATHETERS WITH SOLID SLIPPERY SURFACES TO COMBAT INFECTION AND THROMBOSIS - ABSTRACT THE…$314.3K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Jul 22, 2026 – Jul 22, 2026· R43HL184590
  2. ENHANCED PROSTHETIC VASCULAR GRAFT FUNCTION BY LOCAL RELEASE OF NITRIC OXIDE - ABSTRACT ENDOGRAFT INFECTION, NEOINTIMAL PROLIFERATION, AND…$311.8K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Aug 30, 2024 – Feb 5, 2026· R41HL176245

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2023–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. INFLO MEDICAL INC$747.4K
    IRVINE, CA · 100% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  2. BUGSEQ INC.$747.5K
    SAN FRANCISCO, CA · 100% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  3. CURIEDX, INC$748.9K
    BALTIMORE, MD · 100% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.